Homepage
A New Biology and Testing Website Is Coming
Soon, you’ll be able to explore WuXi Biology and Testing capabilities in one place, making it easier to find integrated solutions across drug discovery and development. Watch for our new website in late October.
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and beyond. Our world-class discovery platform is backed by nearly 3,000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules and oligonucleotides to peptides and antibodies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Webinar
Advancing Metabolic Disease Drug Development
Advancing Metabolic Disease Drug Development
VIEW WebinarLatest Webinar
Integrated Strategies for Advancing CNS Drug Development
Integrated Strategies for Advancing CNS Drug Development
VIEW WebinarT-Cell Engagers: Integrated Workflow to Advance TCE Candidates
VIEW VideoLatest Article
In Vivo CAR-T: An Integrated Framework
In Vivo CAR-T: An Integrated Framework from Preclinical Development to Clinical Bioanalysis
VIEW ArticleSimultaneous In Vitro Profiling of Anticancer Efficacy and Toxicity
VIEW PosterLatest Poster
EpCAM-CD3 BsAb-Encoding mRNA Suppresses Lung Tumors
EpCAM-CD3 BsAb-Encoding mRNA Suppresses Lung Tumor Growth
VIEW PosterLatest Poster
Synthetic-Lethality Screening with PARP1 inhibition
Synthetic-Lethality Screening with PARP1 inhibition
VIEW PosterLatest Poster
In Vitro and In Vivo Efficacy of CAR-T...
In Vitro and In Vivo Efficacy of CAR-T Delivery
VIEW PosterLatest Presentation
In Vivo Evaluation of VEGF-Targeted Bispecific Antibodies
In Vivo Evaluation of VEGF-Targeted Bispecific Antibodies
VIEW PresentationLatest Presentation
Drug-Resistant KRAS G12D Lung Cancer Models
Drug-Resistant KRAS G12D Lung Cancer Models
VIEW Presentation
